Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of oral tolerance induction by Kakkonto in food allergy
jRCTs041180068Completed
- Sponsor
- Tianjin Natural Medicine Biotechnology Research Institute
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of kakkonto in food allergy (2 arms), sponsored by Tianjin Natural Medicine Biotechnology Research Institute. Primary endpoints: Induced reaction during 24 weeks of treatment, Change of dose threshold in oral food challenge after 24 weeks of treatment and 1 more. Started Dec 2017; status: completed.
02
Drugs
kakkonto
03
Conditions
food allergy
Beyond the preview
Go deeper on jRCTs041180068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180068.